ADMA BIOLOGICS, INC. (ADMA) Return on equity 2017–2025
ADMA BIOLOGICS, INC. (ADMA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
30.8%FY2025 · since FY2017: -108.5% → 30.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 30.8% | -25.9 pp |
| FY2024 | 56.6% | +77.5 pp |
| FY2023 | -20.9% | +22.5 pp |
| FY2022 | -43.4% | +7.4 pp |
| FY2021 | -50.8% | +35.1 pp |
| FY2020 | -85.8% | +98.5 pp |
| FY2019 | -184.3% | +148.2 pp |
| FY2018 | -332.5% | -224.0 pp |
| FY2017 | -108.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice